Alyeska Investment Group, L.P. Insmed Inc Transaction History

Alyeska Investment Group, L.P.

$23.4 Billion
Q1 2025

A detailed history of Alyeska Investment Group, L.P. transactions in Insmed Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 735,000 shares of INSM stock, worth $74.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

735,000

Previous 935,779 21.46%

Holding current value

$74.7 Million

Previous $64.6 Million 13.21%

% of portfolio

0.24%

Previous 0.26%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.25 - $83.83 $13.1 Million - $16.8 Million	-200,779 Reduced 21.46%	735,000 $56.1 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $12.5 Million - $14.4 Million	188,377 Added 25.2%	935,779 $64.6 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $19.8 Million - $25.2 Million	318,598 Added 74.3%	747,402 $54.6 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $5.03 Million - $15.9 Million	228,804 Added 114.4%	428,804 $28.7 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $5.14 Million - $5.99 Million	200,000 New	200,000 $5.43 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $1.19 Million - $1.53 Million	-72,516 Reduced 36.26%	127,484 $2.69 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $813,000 - $1.09 Million	50,000 Added 33.33%	200,000 $3.41 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $2.55 Million - $3.47 Million	150,000 New	150,000 $3 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $2.01 Million - $3.11 Million	-124,654 Reduced 46.44%	143,765 $3.43 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $1.13 Million - $1.87 Million	72,634 Added 37.1%	268,419 $4.73 Million
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $4.38 Million - $6.13 Million	-190,587 Reduced 49.33%	195,785 $0
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $752,900 - $1.12 Million	-37,645 Reduced 8.88%	386,372 $9.14 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $2.4 Million - $3.64 Million	110,480 Added 35.24%	424,017 $9.55 Million
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $487,342 - $585,991	18,439 Added 6.25%	313,537 $9.78 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $3.43 Million - $9.21 Million	295,098	295,098 $9.21 Million

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. Insmed Inc Transaction History